Cargando…
Knockdown of DLK4 inhibits non-small cell lung cancer tumor growth by downregulating CKS2
Non-small cell lung cancer (NSCLC) accounts for 85% of all lung cancer cases and is considered as the most common type of cancer. DLX4 was originally identified as a β-globin gene suppressor in red blood cells, which plays critical roles in several types of cancers. However, the role and related mec...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
De Gruyter
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10512446/ https://www.ncbi.nlm.nih.gov/pubmed/37744456 http://dx.doi.org/10.1515/biol-2022-0720 |